Clinical Trial Update: Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures [Phase 4]

View source ↗

Summary

Clinical trial update for a chitosan-based hemostasis pad used after invasive percutaneous procedures in coronary artery disease patients; the Phase 4 trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Hemostasis Pad Using Chitosan

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Coronary Artery Disease, Puncture | Phase 4 | Status: UNKNOWN